✦ LIBER ✦

Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines

✍ Scribed by Guy W. Tillinghast; Jason Partee; Paul Albert; Jenny M. Kelley; Kenneth H. Burtow; Kathleen Kelly

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 387 KB
Volume: 37
Category: Article
ISSN: 1045-2257
DOI: 10.1002/gcc.10195

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

EP300 (p300) and CREBBP (CBP) are highly related transcriptional co‐activators possessing histone acetyltransferase activity. These proteins have been implicated in coordinating numerous transcriptional responses that are important in the processes of proliferation and differentiation. A role for EP300 and CREBBP as tumor suppressors in cancer has been suggested by the fact that they are targeted by viral oncogenes; there is an increased incidence of hematologic malignancies in mice monoallelic for CREBBP; and loss, albeit at a low frequency, of both EP300 alleles in epithelial cancers has been observed. Because the level of EP300/CREBBP appears to have a critical effect on integrating certain transcriptional processes, we sought to determine whether a loss in the combined gene dosage of EP300 and CREBBP might play a role in cancer. Accordingly, we screened a panel of 103 cell lines for loss of heterozygosity and found 35 and 51% LOH for the CREBBP and EP300 loci, respectively. Concordant loss of CREBBP and EP300 was not associated with mutations in important regions of the remaining EP300 or CREBBP genes. In addition, there did not appear to be a statistically significant selection in cancer cells, stratified by various criteria, for the concordant loss of EP300 and CREBBP. We conclude that EP300 and CREBBP rarely act as classical tumor suppressors in human cancer. Published 2003 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Molecular genetic analysis of chromosome

Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines

✍ Sarah V. Williams; Kathryn D. Sibley; Alison M. Davies; Hiroyuki Nishiyama; Nick 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

## Abstract Underrepresentation of chromosome 9 is a common finding in bladder cancer. Frequent loss of the whole chromosome suggests the presence of at least one relevant tumor suppressor gene on each arm. Candidate regions identified by loss of heterozygosity (LOH) analysis include a region at 9p

Analysis of genomic DNA alterations and

Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines

✍ Stephan Gysin; Paula Rickert; Kumar Kastury; Martin McMahon 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB

## Abstract Genomic alterations influencing the expression and/or activity of tumor suppressors or oncogenes such as __KRAS2__, __CDKN2A__, __TP53,__ and __DPC4__ have been directly implicated in the initiation and progression of human pancreatic adenocarcinoma. In an effort further to systematical

Comparison between the clonogenic, MTT,

Comparison between the clonogenic, MTT, and SRB assays for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell line

✍ Dorota Banasiak; Anthony R. Barnetson; Ross A. Odell; Hedy Mameghan; Pamela J. R 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB 👁 2 views

Using a series of human bladder cancer cell lines and an immortalised normal ureteral cell line, radiosensitivities measured by three different methods after a single dose of X-radiation are compared. Clear differences between cell survival curves obtained using the clonogenic, microtetrazoline (MTT

Amplification of the topoisomerase ii α

Amplification of the topoisomerase ii α gene in a non-small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase ii α and β loci in normal tissue

✍ W. Nicol Keith; Robert Brown; K. B. Tan 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

n sylvan la (K. B.T.) DNA was prepared from normal tissue and I9 lung cancer cell lines. Using probes which detect restriction fragment length polymorphisms at both the topoisomerase II u and p loci, heterozygosity was detected at a frequency of 0. I 7 and 0.37 for the

Relationship between the parameters cell

Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines

✍ Marij J.P. Welters; Anne Marie J. Fichtinger-Schepman; Robert A. Baan; Mario A.J 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB 👁 2 views

Patients with head and neck squamous cell carcinoma (HNSCC) treated with cisplatin show a large inter-individual variation in tumor response. Little is known about factors that contribute to this variation. The aim of our study was to correlate the sensitivity to cisplatin with a number of cellular

The effects of γ-interferon combined wit

The effects of γ-interferon combined with 5-fluorouracil or 5-fluoro-2′-deoxyuridine on proliferation and antigen expression in a panel of human colorectal cancer cell lines

✍ Ingrid W. H. M. Maas; Epie Boven; Herbert M. Pinedo; Hennie M. M. Schlüper; Hidd 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 840 KB

Gamma-Interferon (IFN-y) and the antimetabolites 5fluorouracil(5-FU) and 5-fluoro-2'-deoxyuridine (FUdR) were investigated as individual agents and in combination for their in vitro antiproliferative capacity and for their effect on the expression of HLA class-I antigen, carcinoembryonic antigen (CE